Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

10.98
Delayed Data
As of 3:58pm ET
 -0.025 / -0.23%
Today’s Change
7.33
Today|||52-Week Range
13.70
-9.67%
Year-to-Date

Today’s Trading

Previous close11.00
Today’s open11.10
Day’s range10.80 - 11.15
Volume129,203
Average volume (3 months)249,485
Market cap$273.0M
Dividend yield--
Data as of 3:58pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-22.42%
Earnings growth (this year)-24.69%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+4.22%
P/E ratioNM
Price/Sales10.44
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
ZYNEZynerba Pharmaceutic...0.000.00%
NERVMinerva Neuroscience...-0.08-0.97%
DVAXDynavax Technologies...-0.08-1.33%
CMRXChimerix Inc-0.17-2.76%
Data as of 3:58pm ET, 04/28/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$28.9M
Annual profit (last year)-$69.7M
Net profit margin-238.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Michael P. Smith
Corporate headquarters
Emeryville, California

Forecasts